Wednesday, November 25, 2020

Tag: NervGen Pharma

NervGen’s NVG-291 brings New Hope for People With Spinal Cord Injuries

Published: September 12, 2020

(NAPSI)—If you or someone you care about is ever among the approximately 17,700 Americans who each year, according to The Journal of American Medical Association, suffer a new spinal cord injury or the hundreds of thousands that continue to live with a spinal cord injury, you may be relieved to learn about recent research.

6 key developments in spinal cord injury research

Published: February 14, 2020

Here are six key updates in the treatment of spinal cord injuries in the past six months:

The Tim and Caroline Reynolds Center for Spinal Stimulation at Kessler Foundation opened in East Hanover, N.J., in January. The facility has more than 50 researchers focusing on spinal stimulation research and restoring function in people with paralysis. Gail Forrest, PhD, who specializes in applying electrical stimulation to spinal cord injury research, was appointed director of the center.